Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (111-120 of 386) with videos related to

Pageof 39
Sort By:
Emergency Medicine Australasia : EMA|January 15, 2016
Ventilator-assisted preoxygenation: Protocol for combining non-invasive ventilation and apnoeic oxygenation using a portable ventilatorSteven Grant, Faisal Khan, Gerben Keijzers, et al.
Cancer Biology & Therapy|January 8, 2009
PI3K: A rational target for ovarian cancer therapy?Paul Dent, Steven Grant, Paul B Fisher, et al.
Cancer Biology & Therapy|December 17, 2009
Minting a new class of polo-like-kinase inhibitorsPaul Dent, David T Curiel, Steven Grant, et al.
Molecular Pharmacology|May 5, 2006
The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanismNing Gao, Lora Kramer, Mohamed Rahmani, et al.
Air Medical Journal|May 26, 2025
Ventilator-Assisted Preoxygenation for Patients With Diabetic Ketoacidosis: A Novel Case SeriesAkmez Latona, Richard Pellatt, David Wedgwood, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
Approaches for monitoring signal transduction changes in normal and cancer cellsPaul Dent, Philip B Hylemon, Steven Grant, et al.
Cancer Research|October 3, 2007
The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulationRoberto R Rosato, Jorge A Almenara, Stefanie Coe, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 28, 2009
Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapyPaul Dent, David T Curiel, Paul B Fisher, et al.
Leukemia Research|November 15, 2011
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanismRoberto Rosato, Stefanie Hock, Paul Dent, et al.
Emergency Medicine Australasia : EMA|March 20, 2024
Ventilator-assisted preoxygenation in an aeromedical retrieval settingAkmez Latona, Richard Pellatt, David Wedgwood, et al.
Pageof 39

Showing results (111-120 of 386) with videos related to

Sort By:
Pageof 39
Emergency Medicine Australasia : EMA|January 15, 2016
Ventilator-assisted preoxygenation: Protocol for combining non-invasive ventilation and apnoeic oxygenation using a portable ventilatorSteven Grant, Faisal Khan, Gerben Keijzers, et al.
Cancer Biology & Therapy|January 8, 2009
PI3K: A rational target for ovarian cancer therapy?Paul Dent, Steven Grant, Paul B Fisher, et al.
Cancer Biology & Therapy|December 17, 2009
Minting a new class of polo-like-kinase inhibitorsPaul Dent, David T Curiel, Steven Grant, et al.
Molecular Pharmacology|May 5, 2006
The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanismNing Gao, Lora Kramer, Mohamed Rahmani, et al.
Air Medical Journal|May 26, 2025
Ventilator-Assisted Preoxygenation for Patients With Diabetic Ketoacidosis: A Novel Case SeriesAkmez Latona, Richard Pellatt, David Wedgwood, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
Approaches for monitoring signal transduction changes in normal and cancer cellsPaul Dent, Philip B Hylemon, Steven Grant, et al.
Cancer Research|October 3, 2007
The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulationRoberto R Rosato, Jorge A Almenara, Stefanie Coe, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 28, 2009
Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapyPaul Dent, David T Curiel, Paul B Fisher, et al.
Leukemia Research|November 15, 2011
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanismRoberto Rosato, Stefanie Hock, Paul Dent, et al.
Emergency Medicine Australasia : EMA|March 20, 2024
Ventilator-assisted preoxygenation in an aeromedical retrieval settingAkmez Latona, Richard Pellatt, David Wedgwood, et al.
Pageof 39